Skip to main content
Back
Activeted-389765-2026

Reagents for HLA Typing

We are seeking ongoing supplies of diagnostics and consumables for immunogenetic testing using real-time PCR. This is for high-resolution HLA typing, including free software leasing.

CZK 7,860,000
View original source

CONTRACTING AUTHORITY

Name

Institut klinické a experimentální medicíny

City

Praha

Country

CZ

CLASSIFICATION

Procedure Type

Open Procedure

Contract Type

Supplies

Main CPV

33694000, Diagnostic agents.

Other CPV

33141625, Diagnostic kits.

38951000, Real-time Polymerase Chain Reaction (PCR) equipment.

33141000, Disposable non-chemical medical consumables and haematological consumables.

ADDITIONAL DETAILS

EU Funded

Yes

Electronic Submission

Required

Legal Basis

32014L0024

DEADLINES & TIMELINE

Submission Deadline

29 days remaining

(LOT-0001)

Published

TENDER DOCUMENTS

29 days remaining

Similar Tenders

Explore CPV 33
CZK 2.8M

Service Support for the Kredit Information System

We are seeking a provider for comprehensive service support, maintenance, and development of the Kredit information system. The goal is to ensure smooth operation and adaptation to future requirements.

Institut klinické a experimentální medicíny

·Praha
Deadline:July 08, 2026
CZK 237.4M

Antiviral Drugs for Hepatitis C (Glecaprevir/Pibrentasvir)

We are seeking regular supplies of oral antiviral medications for treating Hepatitis C with Glecaprevir and Pibrentasvir. This treatment aims to provide care for patients within approved indications.

Institut klinické a experimentální medicíny

·Praha
Deadline:July 02, 2026
CZK 8M

Access Control System Modernization with Service Support

Expansion and modernization of the existing HID AERO access control system, including installation at 71 doors and replacement of 410 readers. Includes 24 months warranty and 48 months service.

Institut klinické a experimentální medicíny

·Praha
Deadline:June 29, 2026
CZK 15.3M

Eliquis (Apixaban) for Oral Administration

We are seeking supplies of the oral medication Eliquis (active ingredient apixaban) for treating patients in approved indications. This is for the supply of patients at the Institute for Clinical and Experimental Medicine.

Institut klinické a experimentální medicíny

·Praha
Deadline:June 26, 2026

Find matching tenders automatically

With Patterno-HIT, receive relevant tenders daily, automatically filtered to your company profile.

Book Demo Now